002873
vs
S
Shanghai Composite
002873
Over the past 12 months, Guiyang Xintian Pharmaceutical Co Ltd has underperformed Shanghai Composite, delivering a return of +4% compared to the Shanghai Composite's +24% growth.
Stocks Performance
002873 vs Shanghai Composite
Performance Gap
002873 vs Shanghai Composite
Performance By Year
002873 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Guiyang Xintian Pharmaceutical Co Ltd
Glance View
Guiyang Xintian Pharmaceutical Co., Ltd. engages in the production, sale, research and development of Chinese medicines. The company is headquartered in Guiyang, Guizhou and currently employs 1,019 full-time employees. The company went IPO on 2017-05-19. The firm manufactures its products in the forms of capsules, mixture, granules, syrup, gel and tablets. The Company’s main products include Ningmitai Capsule, Kuntai Capsule, Kushen Gel and Xiaokucao Oral Liquid .The Company distributes its products in the domestic market.
